SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Altschul, MD
Montefiore Health System
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Endeavor Health - Northwest Community Hospital
Arlington Heights, Illinois, United States
- Endeavor Health - Evanston Hospital
Evanston, Illinois, United States
- Endeavor Health- Edward Hospital
Naperville, Illinois, United States
- the Cooper Health System
Camden, New Jersey, United States
- Nyu Langone Health
New York, New York, United States
- Stony Brook University Hospital
Stony Brook, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Aug 2024
- Primary completion
- 10 Sept 2026
- Completion
- 10 Sept 2030
- Last update posted
- 16 Jan 2026
- Registered enrollment
- 279
- Registry id
- NCT05831202
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.